Schedule

NCS 19th Annual Meeting

Schedule

Please see below to reference the schedule for the NCS 19th Annual Meeting. Please note that the schedule is subject to change. All times are listed in Central Daylight Time (CDT).

Friday, October 22

8:00 a.m. – 12:00 p.m.
1:00 p.m. – 5:00 p.m. 

Monday, October 25

8:00 a.m. – 12:00 p.m.
1:00 p.m. – 5:00 p.m. 

Tuesday, October 26

8:00 a.m. – 12:00 p.m.
1:00 p.m. – 5:00 p.m.
1:00 p.m. – 3:00 p.m. 
3:00 p.m. – 5:00 p.m. 
5:00 p.m. – 7:00 p.m.
Sunset Soiree in the Exhibit Hall
7:15 p.m. – 8:15 p.m.

Wednesday, October 27

7:30 a.m. – 8:30 a.m.
Business Meeting and Awards Ceremony
8:45 a.m. – 10:15 a.m.
Clinical Trials – Plenary Session
10:15 a.m. – 11:00 a.m.
Morning Break in the Exhibit Hall
11:00 a.m. – 12:00 p.m.
Concurrent Session 1
1:15 p.m. – 2:15 p.m.
Keynote Session
2:30  p.m. – 4:00 p.m.
Concurrent Session 2
4:15 p.m. – 5:15 p.m. 
Poster Session 1
5:30 p.m. – 6:30 p.m.
Evening Break in the Exhibit Hall
6:30 p.m. – 8:00 p.m. 
INCC Session/Networking

Thursday, October 28

7:00 a.m. – 7:50 a.m.
Run for Research
8:00 a.m. – 9:30 a.m.
Concurrent Session 3
9:45 a.m. – 10:45 a.m.
Poster Session 2
10:45 a.m. – 11:30 a.m.
Morning Break in the Exhibit Hall
11:45 a.m. – 12:45 p.m.
Concurrent Session 4
1:45 p.m. – 2:45 p.m.
Concurrent Session 5
2:45 p.m. – 3:30 p.m.
Afternoon Break in the Exhibit Hall
3:45 p.m. – 4:45 p.m.
Concurrent Session 6
5:00 p.m. – 6:00 p.m.
Concurrent Session 7
6:00 p.m. – 7:00 p.m. 
Evening Break in the Exhibit Hall

Friday, October 29

8:00 a.m. – 9:00 a.m.
Concurrent Session 8
9:15 a.m. – 10:15 a.m.
Concurrent Session 9
10:15 a.m. – 11:15 a.m.
Morning Break in the Exhibit Hall
11:30 a.m. – 1:00 p.m.
Concurrent Session 10
1:15 p.m. – 2:30 p.m.
Closing Keynote 


*Additional registration fees are required.

Schedule

Please see below to reference the schedule for the NCS 19th Annual Meeting. Please note that the schedule is subject to change. All times are listed in Central Daylight Time (CDT).

Tuesday, October 19, Wednesday, October 20 and Thursday, October 21

NCS will again host Specialty Corners ahead of the NCS Annual Meeting. These are free sessions to allow you to network with fellow neurocritical care professionals with the same specialty as you.  Learn More and Register Here.

Friday, October 22

8:00 a.m. – 12:00 p.m.
1:00 p.m. – 5:00 p.m.

Monday, October 25

8:00 a.m. – 12:00 p.m.
1:00 p.m. – 5:00 p.m.
5:15 p.m. – 6:15 p.m.
150.png Professionalism & Leadership Session*

  • Sarah Livesay, DNP, APRN, FNCS, FAAN
  • Jason Makii, PharmD, MBA, BCPS, BCCCP, FCCM, FNCS
  • Catrice Nakamura, RN, MSN
  • Wade Smith, MD, PhD
  • Panos Varelas, MD, PhD, FNCS

Tuesday, October 26

8:00 a.m. – 12:00 p.m.
1:00 p.m. – 3:00 p.m.
1:00 p.m. – 5:00 p.m.
3:15 p.m. – 5:15 p.m.
5:00 p.m. – 7:00 p.m.
150.png Sunset Soiree in the Exhibit Hall
7:15 p.m. – 8:15 p.m.

Wednesday, October 27

7:30 a.m. – 8:45 a.m.
150.png Business Meeting and Awards Ceremony
8:45 a.m. – 10:15 a.m.
150.png Clinical Trials – Plenary Session
  • SAHRANG: Subarachnoid Hemorrhage Recovery and Galantamine- A pilot multicenter randomized placebo controlled trial, H. Alex Choi, MD
  • PILLAR trial of CSF dialysis, Marc Babi, MD
  • Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH) Phase 2a trial, Daniel Hanley, MD
  • Ceftriaxone to Prevent Pneumonia and Inflammation in Comatose Patients after Out-of-Hospital Cardiac Arrest (PROTECT): A randomized-controlled trial and microbiome, David Gagnon, PharmD, BCCCP, FCCM
  • The American Heart Association-Bugher Foundation Network of Excellence in Hemorrhagic Stroke, Jonathan Rosand, MD
10:15 a.m. – 11:00 a.m.
150.png Exhibit Hall Break
10:45 a.m. – 11:45 a.m.
150.png Concurrent Session 1
Critical Care in the Neuro-ICU
  • Post-cardiac Arrest Care in the Pediatric Patient, Matthew Kirschen, MD, PhD
  • Refractory Hypoxemia in the NeuroICU, Amol Patil, MD, FCCP
  • Shock in the NeuroICU, Aleksandra Yakhkind, MD, MS
Traumatic Brain Injury: Recent Advances and the Future
  • Management of Traumatic Dissection and Cerebral Venous Sinus Thrombosis, Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS
  • What is the Future of Pediatric TBI Management?, Courtney Robertson, MD
  • Assessment of Autoregulation in Severe TBI, Andreas Kramer, MD
  • Systematic Review of Tranexamic Acid for the Treatment of TBI, Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP
NCS Guidelines Session
  • Published Project Review, New GUIDE Process for Guidelines, Update on Ongoing Guidelines, Theresa Human, PharmD, PhD, BCPS, FNCS, Venkatakrishna Rajajee, MBBS
  • SAH Guideline Recommendations, Miriam Treggiari, MD, PhD, MPH, Alejandro Rabinstein, MD
  • Prognostication Methods and Update, Susanne Muehlschlegel, MD, MPH, FNCS, FCCM, FAAN, Katja Wartenberg, MD
  • Prognostication in Cardiac Arrest, Venkatakrishna Rajajee, MBBS, Panayiotis Varelas, MD, PhD, FNCS, FAAN
  • Prognostication in GBS, Katharina Busl, MD
1:15 p.m. – 2:15 p.m.
150.png Opening Keynote: Leadership During the COVID-19 Crisis
Professor Maurizio Cecconi, MD, FRCA, FFICM, MD(Res)
2:30 p.m. – 4:00 p.m.
150.png Concurrent Session 2
Acute Stroke Management: Breaking Gaps Resiliently
  • Developing an International Stroke Unit Certification Process (Global Stroke Alliance), Sheila Martins, MD, PhD
  • Thrombectomy 2020: Project Description and Current Goals, Santiago Ortega-Gutierrez, MD, MSc, FAHA, FSVIN
  • Angels Initiative: An Educational Program Set to Bring Health Workers Related to Stroke Care Worldwide to an Optimal Knowledge Level, Klepper Alfredo Garcia, MD, FACP
  • The Brazilian Success: Resilient Trail Conclusions, Gisele Silva, MD, MPH, PhD
Multidisciplinary Stroke Session: Transport, TNK and Thrombophilia
  • Code Stroke: A Critical Care Transport Primer, Amado Alejandro Baez, MD, MPH, PhD
  • Pediatric Stroke Code: Early Management of the Child with Stroke, Melissa Chung, MD
  • The Case for Tenecteplase: TNK as Primary Fibrinolytic in Ischemic Stroke, Mitchell Daley, PharmD, FCCM, BCCCP
  • COVID-19 and Hypercoagulable States, Lori Kennedy Madden, PhD, ACNP-BC
Can Ultrasound be the Holy Grail of Noninvasive Monitoring in the NeuroICU?
  • Da Vinci Code: Transcranial Doppler Assessment as a Neuromonitoring Tool - Pediatric Considerations, Nicole F. O'Brien, MD
  • Da Vinci Code: Transcranial Doppler Assessment for Coma and Cerebral Edema - Adult Considerations, Sebina Bulic, MD
  • Why Listen When You Can See? Point of Care Applications for Heart, Lung and Abdominal Ultrasound in Neurocritical Care, Atul Kalanuria, MD
  • Littera Scripta Manent, POCUS Documentations, Credentialing, and Billing, Kelly Rath, DNP, ACNP
4:15 p.m. – 5:15 p.m.
150.png Poster Session 1
5:30 p.m. – 6:30 p.m.
150.png Exhibit Hall Break
6:30 p.m. – 8:00 p.m.
150.png INCC Keynote: NCS Journey from WINCC to INCC: Revisiting the Role of Professional Medical Societies in Healthcare Diversity
Nerissa U. Ko, MD, MAS

Thursday, October 28

7:00 a.m. – 7:50 a.m.
150.png Run for Research
8:00 a.m. – 9:30 a.m.
150.png Concurrent Session 3
NCS/AHA Consensus Statement on Critical Care Management of Cardiac Arrest Survivors
  • Overview of the NCS/AHA Consensus on Critical Care Management of Cardiac Arrest Survivors: Objectives, Scope and Process, Romergryko Geocadin, MD
  • Acute Neurologic Injury in Patients Post-Cardiac Arrest: Seizures, Brain Edema, and Intracranial Pressure, Karen Hirsch, MD
  • Acute Systemic Injury in Patients Post-Cardiac Arrest: Cardiac, Pulmonary, Renal, and Endocrine, Katherine Berg, MD
  • Acute Systemic Injury in Patients Post-Cardiac Arrest 2: GI, Endocrine, Hematologic and Infectious Concerns, Fabio Silvio Taccone, MD, PhD
  • Neurologic Assessments, ICU Protocols, and Team-Based Treatment in Post-Cardiac Arrest Patients, Sarah Livesay, DNP, APRN
Neuro-COVID: A Global Perspective - Part I
  • Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-Neuro COVID): Latest Progress and Results on Neurologic Impact of COVID-19 - A North American Perspective, Sherry Chou, MD, MSc, FNCS, FCCM
  • China's Experience with Neuro COVID, Yingying Su, MD
  • Neuro COVID in EU Nations: European Academy of Neurology ENERGY Study Perspectives, Raimund Helbok, MD
  • Latin America Experience with Neuro COVID, Telmo Fernández-Cadena, MD
  • From MERS to COVID: Transmission Patterns and Pathogenesis - The MENA Experience, Yaseen Arabi, MD, FCCP, FCCM, ATSF
  • Neuro COVID in the Pediatric Population: GCS-COVID - Pediatrics Arm, Ericka Fink, MD, MS
Brain Multi-organ Axis: Implications in Neurocritical Care
  • The Brain and the Gut and Liver Axis in Neurocritical Care, Alexandra Reynolds, MD
  • The Brain and the Kidney Axis in Neurocritical Care, Shivani Ghoshal, MD
  • The Brain and Heart and Lung Axis in Neurocritical Care, Jennifer Kim, MD, PhD
  • The Brain and Multi-organ Axis Considerations in the Pregnant Woman, Erika Bassett, PA-C
8:30 a.m. – 11:30 a.m.
150.png Exhibit Hall Open
9:45 a.m. – 10:45 a.m.
150.png Poster Session 2
10:45 a.m. – 11:30 a.m.
150.png Exhibit Hall Break
11:30 a.m. – 12:30 p.m.
150.png Concurrent Session 4
Ethics Education in a Shifting Medical Landscape
  • Decision Makers: Discussing Ethical Concerns Surrounding COVID and Rationing of Resources, Stephen Trevick, MD, Audrey Paulson, DNP, RN, FNP-BC, CCRN, CNRN, SCRN
  • Cultural Humility in the Era of COVID, Diana Greene-Chandos, MD, John Paul Sanchez, MD, MPH
  • Lawmakers: Revising the Uniform Definition of Death Act, Ariane Lewis, MD
  • Adolescent Decision-making in the ICU, Jessica McFarlin, MD
Optimizing Care Quality Metrics and Reimbursement in Neurocritical Care
  • Benchmarking and Publicly Reported Quality Rankings: the Neurocritical Care Relevant Measures that Matter, Casey Olm-Shipman, MD, MS
  • Reducing the Mortality Index in Neurocritical Care through Accurate Documentation, Debra Roberts, MD, PhD
  • Optimization of Documentation for Coding and Revenue Management in Neurocritical Care, Emmaculate Fields, NP
Pediatric Neurocritical Care in the Cardiac Intensive Care Unit (CICU)
  • Neurocritical Care in the CICU, Sherill Caprarola, MD
  • Bedside EEG Monitoring: Beyond Seizure Detection, Shavonne Massey, MD, MSCE
  • Neurological Complications Associated with Ventricular Assist Devices, Lori Jordan, MD, PhD
  • Neonatal Brain Injury Associated with Congenital Heart Disease, Jessica Carpenter, MD
12:45 p.m. – 1:35 p.m.
150.png Industry Lunch Symposia Opportunity
2:00 p.m. – 3:00 p.m.
150.png Concurrent Session 5
Neuro-COVID: A Global Perspective - Part II
  • Evidence-based Treatment for Severe COVID-19, Amanda Rosen, PharmD, BCCCP, Aph
  • Nurses at the Front Line of COVID-19 in South Africa, Isabel Coetzee, PhD
  • Neuro COVID in Europe: A German Perspective - PANDEMIC Study, Julian Bösel, MD, FNCS, FESO
  • NeuroDatabank and NeuroBiobank of COVID, Jennifer Frontera, MD
Adult & Pediatric Updates in Status Epilepticus: Point of Care EEG, NORSE & RSE
  • Point of Care EEG Monitoring in the ICU Across the Lifespan, Ayham Alkhachroum, MD
  • NORSE & FIRES, Katrina Peariso, MD, PhD
  • Updates in the Management of Refractory Status Epilepticus, Caroline Der-Nigoghossian, PharmD
Neuroinfections/Neuroinflammation
  • Post-infectious Encephalitis, Linda Wendell, MD
  • Checkpoint Inhibitor Toxicities in Neurocritical Care, Lauren Sutton, PharmD
  • The Bidirectional Link between the Acutely Injured Brain and the Gut Microbiome, Ahmad Riad Ramadan, MD
3:00 p.m. – 3:45 p.m.
150.png Exhibit Hall Break
3:45 p.m. – 4:45 p.m.
150.png Concurrent Session 6
NCS Debates
  • Machine Learning Algorithms are More Effective at Guiding Optimal Patient Care Decisions, Rajat Dhar, MD
  • Clinical Experience and Clinical Acumen are Superior to Machine Learning Algorithms in Ensuring Optimal Patient Care Decisions, Soojin Park, MD
  • The Presence of Multidisciplinary Multiprofessional Neurocritical Care Teams at the Bedside is Needed for Best Patient Care, Megan Brissie, DNP, RN, ACNP-BC, FNCS
  • Multidisciplinary Multiprofessional Neurocritical Care Provided by Telemedicine is not Inferior to Traditional Care Provided at the Bedside, Sarah Nelson, MD, MPH
  • Prothrombin Complex Concentrate Remains the Best Method for Reversal of Coagulopathy due to Direct Oral Anticoagulants in Patients with Neurological Injuries, G. Morgan Jones, PharmD, BCCCP, FCCM
  • Targeted Antibody Therapy Directed at Direct Oral Anticoagulants are the Best Method for Reversal of Coagulopathy due to Direct Oral Anticoagulants in Patients with Neurological Injuries, Nicole Davis, PharmD, BCCCP
Multimodality Monitoring: Next Generation Noninvasive Neuromonitoring
  • Noninvasive ICP Monitoring, Francis Bernard, MD, FRCPC, FNCS
  • Pragmatic Uses of Bedside Pupillometry, Gregory Hawryluk, MD, PhD, FRCSC
  • Innovative EEG: Quantitative and Portable Monitoring, Sahar Zafar, MD, MSc
  • Brain Tissue Oxygen Neuromonitoring in Pediatric Patients at Risk for Intracranial Hypertension, Shih-Shan Lang, MD
Translational Science in Neurocritical Care: How We Do It
  • Cerebral Edema after Acute Ischemic Stroke: How We Built Our Program, Kevin Sheth, MD, FAHA, FCCM, FNCS, FAAN, FANA
  • Translational Research in Acute Brain Injuries at Duke, Michael "Luke" James, MD
  • Oh, the Places You Will Go! A Bayesian Approach to Translational TBI Research, Ruchira Menka Jha, MD, MSc
  • How we Approach Subarachnoid Hemorrhage in our Lab, Jose Javier Provencio, MD
5:00 p.m. – 6:00 p.m.
150.png Concurrent Session 7
Oral Platform Presentations
  • Blood Clot Burden can Differentiate Perimesencephalic Subarachnoid Hemorrhage from Aneurysmal Etiology, Daniel Mandel, MD
  • Leucine-rich Alpha-2-glycoprotein 1 is Systemic Biomarker of Early Brain Injury and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage, H. Alex Choi, MD
  • Evaluation of the Interaction Between Anti-Platelet Therapy and Intraoperative Opioids in Patients Undergoing Neuroendovascular Stenting, Blake Robbins, PharmD, MBA
  • Predictive Value of Structural Connectome Changes in the Acute Phase of Aneurysmal Subarachnoid Hemorrhage: A Graph Analysis of Diffusion Tensor Imaging Data, Sarah Nelson, MD, MPH
  • Esmolol Reduces Anterior Circulation Cerebral Perfusion Compared to Nicardipine, Michael Gezalian, MD
  • Sleep Disturbances and Quality of Life in Children after Critical Care Hospitalization, Amy Colagiovanni, MD Candidate, 2023
Acute Stroke Patient Management when ICU Beds are Scarce
  • Global Issues and Provision of Stroke Care, Muhammed Ezzat Zaghlouleh, MD
  • Implementing a Low Intensity Monitoring Thrombolysis Protocol, Diane Clark, MS, ACNP-BC, CCNS, CCRN
  • Special Populations in Thrombolysis Administration, Gabe Fontaine, PharmD, MBA, BCPS
Complexities of Mechanical Ventilation and Airway Management in the NeuroICU Patient
  • Prone Ventilation in the NeuroICU Patient- ICP vs V/Q, Vasisht Srinivasan , MD
  • Bedside Nursing Considerations for Prone Positioning in the NeuroICU: Bolts and Flaps and Bairs, Oh My!, Arianna Barnes, RN
  • Mechanical Ventilation and Airway Management Real-time Data Streams - What the Multimodal Monitors Tell Us, Brandon Foreman, MD, MS, FACNS, FNCS
6:00 p.m. – 7:00 p.m.
150.png Exhibit Hall Break

Friday, October 29

8:00 a.m. – 9:00 a.m.
150.png Concurrent Session 8
Traumatic Brain Injury: Improving Short and Long-term Care in TBI
  • Clinical Trial Updates in Traumatic Brain Injury, Theresa Green, RN, PhD
  • Use of Neurostimulants and Mood Stabilizers in TBI Survivors, Casey May, PharmD
  • Neuroendocrine Disturbances and Medical Complications Post TBI, Vishank Shah, MD
  • Post-TBI Syndromes and ICU Survivorship, Rohan Sharma, MD
Time is Brain in ICH: Are we Headed for a Paradigm Shift in the Treatement of ICH?
  • Pathophysiology of Hematoma Development and Resolution, Agnieszka A. Ardelt , MD, PhD, MBA, FAHA
  • Controlling the Hematoma Growth and Removing It: The Role of Medical Management, Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP
  • Removing the Hematoma with Surgery: Still Trying to Show Superiority, Eric Arias, MD
  • From Onset, to Recognition, to Transfer, to Arrival: Is it Time for "Time is Brain" for ICH, Too?, Bethany Young, MSN, RN, AGCNS-BC, CCRN
Late-Breaking Science
  • Proximity Extension Assay Reveals New Proteomic Markers of Cerebral Edema in SAH, H. Alex Choi, MD
  • Connectivity Improves Across Multiple Functional Networks in Patients who Recover from Acute Traumatic Coma, Zachary Threlkeld, MD
  • Validation of an Algorithm for Advance Prediction of Hypotension after Acute Spinal Cord Injury, Haitham Alabsi, DO
  • The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx): Interim Analysis of early epileptiform and seizure incidence, Paul Vespa, MA
9:15 a.m. – 10:15 a.m.
150.png Concurrent Session 9
Brain Death: Evolution of Theory, Practice and Law
  • All Death is Brain Death: A Brain-based Definition of Death, Sam Shemie, MD
  • Potential and Problems in the Evolving Legal Framework for Brain Death, Thaddeus Pope, JD, PhD, HEC-C
  • Management of Pharmacologic Confounders in Determination of Brain Death: It's All About Context!, Salmaan Kanji, PharmD
  • Variability in Brain Death Determination in the PICU: Room for Improvement?, Jennifer MacDonald, MD, PhD
Machine Learning Aids Prognostication after Cardiac Arrest
  • Post-arrest Prognostication and Precision Medicine, Teresa May, DO, MS
  • Quantitative and Machine Learning Approaches to Brain Monitoring Post-Cardiac Arrest, Ed Amorim, MD
  • Advanced Predictive Modeling of Children with Neurological Injury in the PICU using Machine Learning, Neil Munjal, MD
  • Using High Resolution Multimodal Data for Precision Care Post-arrest, Jonathan Elmer, MD, MS
Neuroimaging of Aneurysmal Subarachnoid Hemorrhage—Novel Insights
  • MRI: Could It Help Predict Outcome in SAH?, Sarah Nelson, MD, MPH
  • The Promises of Computational Neuroimaging, Robert Stevens, MD, FCCM
  • SAH and Functional Connectivity in Mice, David Chung, MD, PhD
10:15 a.m. – 11:15 a.m.
150.png Exhibit Hall Break
11:30 a.m. – 1:00 p.m.
150.png Concurrent Session 10
Simulation in Neurocritical Care as Translational Science
  • Simulation Solutions to Neurocritical Care Delivery Deficiencies, Nicholas Morris, MD
  • Simulation Blueprint, Kara L. Curley, MMS, PA-C
  • Simulation in Neurocritical Care: Finding the Right Simulation Solution, Casey Albin, MD
  • Pharmacologic Simulation and Optimizing Pharmacokinetic Outcomes, Jennifer Schultheis, PharmD, BCPS, BCCCP
Rest and the Restless: Is Sleep the Next Frontier in Neurocritical Care?
  • The Risks and Benefits of Frequent Awakenings: How Much is Too Much?, Matthew Maas, MD, MS
  • The Glymphatic System and Sleep, Juan Piantino, MD, MCR
  • If We Can Change, You Can Change: Proposed Practice Models For More Restful ICUs, Byron Carlisle
  • Do The Poppies Really Make Them Sleep?: Not All Sleep Medications Are Created Equal, Mehrnaz Pajoumand, PharmD, BCCP
International Challenge of Curing Coma
  • The International Scientific Challenge of Curing Coma, Gisele Silva, MD, MPH, PhD
  • The Challenge of Neuroethics in Curing Coma, Joseph J. Fins, MD, MACP, FRCP
  • The Challenge of Implementing Care for Coma, Molly McNett, PhD, RN, CNRN, FNCS, FAAN
  • The Challenge of Diagnosis and Prognosis in Children in Coma, Kerri LaRovere, MD
  • Panel: Discussion of the Intersections of these Four Challenges in Curing Coma, Wendy Ziai, MD, MPH, Varina Boerwinkle, MD
1:15 p.m. – 2:30 p.m.
150.png Closing Keynote: One More Summit – Breaking Barriers
Sebastian Carrasco


*Additional registration fees are required.